Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-25 @ 9:27 PM
Study NCT ID:
NCT04288856
Status:
TERMINATED
Last Update Posted:
2023-04-18
First Post:
2020-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-26
First Submit QC Date:
None
Study First Post Date:
2020-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-13
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL